索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]李子昀,赵金忠.膝关节纤维化诊治研究进展[J].国际骨科学杂志,2024,02:105-108.
点击复制

膝关节纤维化诊治研究进展(PDF)

《国际骨科学杂志》[ISSN:1673-7083/CN:31-1952/R]

期数:
2024年02期
页码:
105-108
栏目:
综述
出版日期:
2024-03-25

文章信息/Info

Title:
-
作者:
李子昀; 赵金忠
200233，? 上海交通大学医学院附属第六人民医院运动医学科
Author(s):
-
关键词:
膝关节纤维化; 诊断; 治疗
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-7083.2024.02.006
文献标识码:
-
摘要:
膝关节纤维化是常见的临床并发症，可造成膝关节活动度受限，严重影响了患者生活质量。目前精确诊断和有效治疗成为膝关节纤维化研究的热点。金属抑制技术联合轧造影剂MRI检查可为膝关节纤维化术前规划及术后预后提供精准的定量信息。膝关节纤维化治疗是体系化的，需要药物治疗与非药物治疗共同实施。该文就膝关节纤维化分类、影像学诊断、治疗（非药物与药物治疗）及预后研究进展进行综述。
Abstract:
-

参考文献/References

[1] Kalson NS, Borthwick LA, Mann DA, et al. International consensus on the definition and classification of fibrosis of the knee joint[J]. Bone Joint J, 2016, 98B(11): 1479-1488.
[2] Sanders TL, Kremers HM, Bryan AJ, et al. Procedural intervention for arthrofibrosis after ACL reconstruction: trends over two decades[J]. Knee Surg Sports Traumatol Arthrosc, 2017, 25(2): 532-537.
[3] Namba RS, Cafri G, Khatod M, et al. Risk factors for total knee arthroplasty aseptic revision[J]. J Arthroplasty, 2013, 28(8 Suppl):122-127.
[4] 苗田雨, 王宁宁, 努尔比亚?克其克, 等. 膝关节纤维化的研究进展[J]. 河北医药, 2023, 45(13): 2046-2050.
[5] Mann CJ, Bradley AM, Jones ER, et al. Stiffness post-total knee replacement: a proof of principle study investigating the effect of gene expression analysis of markers of fibrosis[J]. Knee, 2019, 26(4):914-922.
[6] Shelbourne KD, Patel DV, Martini DJ. Classification and management of arthrofibrosis of the knee after anterior cruciate ligament reconstruction[J]. Am J Sports Med, 1996, 24(6): 857-862.
[7] Sprague NF 3rd, O'connor RL, Fox JM. Arthroscopic treatment of postoperative knee fibroarthrosis[J]. Clin Orthop Relat Res, 1982, 166: 165-172.
[8] Sharma M, Sharma S, Upadhyaya AR. Classification-based management of stiff/ankylosed knees[J]. Indian J Orthop, 2021, 55(5): 1158-1174.
[9] Srinivasan R, Wan J, Allen CR, et al. Knee imaging following anterior cruciate ligament reconstruction: the surgeon's and radiologist's perspectives[J]. Semin Musculoskelet Radiol, 2018, 22(4): 386-397.
[10] Attard V, Li CY, Self A, et al. Quantification of intra-articular fibrosis in patients with stiff knee arthroplasties using metal-reduction MRI[J]. Bone Joint J, 2020, 102B(10): 1331-1340.
[11] Zhang L, Yan M, Chen S, et al. Manipulation under anaesthesia versus lysis of adhesions for arthrofibrosis of the knee: a 6-month randomized, multicentre, non-inferiority comparative effectiveness protocol[J]. Ann Palliat Med, 2021, 10(5): 5908-5918.
[12] Dodds JA, Keene JS, Graf BK, et al. Results of knee manipulations after anterior cruciate ligament reconstructions[J]. Am J Sports Med, 1991, 19(3): 283-287.
[13] Rullán PJ, Zhou G, Emara AK, et al. Understanding rates, risk factors, and complications associated with manipulation under anesthesia after total knee arthroplasty (TKA): an analysis of 100,613 TKAs[J]. Knee, 2022, 38: 170-177.
[14] Mayr HO, Brandt CM, Weig T, et al. Long-term results of arthroscopic arthrolysis for arthrofibrosis after anterior cruciate ligament reconstruction[J]. Arthroscopy, 2017, 33(2): 408-414.
[15] Lamba A, Holliday CL, Marigi EM, et al. Arthroscopic lysis of adhesions for arthrofibrosis after anterior cruciate ligament reconstruction[J]. Am J Sports Med, 2023, 51(12): 3149-3153.
[16] Fackler N, Chin G, Karasavvidis T, et al. Outcomes of arthroscopic lysis of adhesions for the treatment of postoperative knee arthrofibrosis: a systematic review[J]. Orthop J Sports Med, 2022,10(9): 23259671221124911.
[17] Wang JH, Zhao JZ, He YH. A new treatment strategy for severe arthrofibrosis of the knee. A review of twenty-two cases[J]. J Bone Joint Surg Am, 2006, 88(6): 1245-1250.
[18] Zhao J. Arthroscopic release of severe flexion- and extension-impeding knee stiffness with inaccessible joint[J]. Arthrosc Tech, 2021, 10(12): e2753-e2765.
[19] Kukreja M, Kang J, Curry EJ, et al. Arthroscopic lysis of adhesions and anterior interval release with manipulation under anesthesia for severe post-traumatic knee stiffness: a simple and reproducible step-by-step guide[J]. Arthrosc Tech, 2019, 8(5): e429-e435.
[20] Bidolegui F, Pereira SP, Pires RE. Safety and efficacy of the modified Judet quadricepsplasty in patients with post-traumatic knee stiffness[J]. Eur J Orthop Surg Traumatol, 2021, 31(3): 549-555.
[21] Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation[J]. Signal Transduct Target Ther, 2017, 2: 17023.
[22] Usher KM, Zhu S, Mavropalias G, et al. Pathological mechanisms and therapeutic outlooks for arthrofibrosis[J]. Bone Res, 2019, 7: 9.
[23] Zheng W, Song J, Zhang Y, et al. Metformin prevents peritendinous fibrosis by inhibiting transforming growth factor-β signaling[J]. Oncotarget, 2017, 8(60): 101784-101794.
[24] Mu Q, Jiang M, Zhang Y, et al. Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells[J]. Onco Targets Ther, 2018, 11: 1767-1776.
[25] Jiang S, Li T, Yang Z, et al. AMPK orchestrates an elaborate cascade protecting tissue from fibrosis and aging[J]. Ageing Res Rev, 2017, 38: 18-27.
[26] Feng Y, Wang S, Zhang Y, et al. Metformin attenuates renal fibrosis in both AMPKα2-dependent and independent manners[J]. Clin Exp Pharmacol Physiol, 2017, 44(6): 648-655.
[27] Ko MT, Huang HC, Lee WS, et al. Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats[J]. J Chin Med Assoc, 2017, 80(8): 467-475.
[28] Gamad N, Malik S, Suchal K, et al. Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: pharmacological effects and molecular mechanisms[J]. Biomed Pharmacother, 2018, 97: 1544-1553.
[29] Luo Y, Xie X, Luo D, et al. The role of halofuginone in fibrosis: more to be explored?[J]. J Leukoc Biol, 2017, 102(6): 1333-1345.
[30] Kallianos SA, Singh V, Henry DS, et al. Interleukin-1 receptor antagonist inhibits arthrofibrosis in a post-traumatic knee immobilization model[J]. Knee, 2021, 33: 210-215.
[31] Poe A, Martinez Yus M, Wang H, et al. Lysyl oxidase like-2 in fibrosis and cardiovascular disease[J]. Am J Physiol Cell Physiol, 2023, 325(3): C694-c707.
[32] Yang N, Cao DF, Yin XX, et al. Lysyl oxidases: emerging biomarkers and therapeutic targets for various diseases[J]. Biomed Pharmacother, 2020, 131: 110791.
[33] Blessing WA, Williamson AK, Kirsch JR, et al. The prognosis of arthrofibroses: prevalence, clinical shortcomings, and future prospects[J]. Trends Pharmacol Sci, 2021, 42(5): 398-415.
[34] Ekhtiari S, Horner NS, de Sa D, et al. Arthrofibrosis after ACL reconstruction is best treated in a step-wise approach with early recognition and intervention: a systematic review[J]. Knee Surg Sports Traumatol Arthrosc, 2017, 25(12): 3929-3937.
[35] Haffar A, Goh GS, Fillingham YA, et al. Treatment of arthrofibrosis and stiffness after total knee arthroplasty: an updated review of the literature[J]. Int Orthop, 2022, 46(6): 1253-1279.
[36] Nwachukwu BU, Mcfeely ED, Nasreddine A, et al. Arthrofibrosis after anterior cruciate ligament reconstruction in children and adolescents[J]. J Pediatr Orthop, 2011, 31(8): 811-817.

备注/Memo

备注/Memo:
基金项目：上海市科学技术委员会科研项目（22dz1204700）
通信作者：赵金忠? E-mail: jzzhao@sjtu.edu.cn
更新日期/Last Update: 2024-03-25